European Case Law Identifier: | ECLI:EP:BA:2007:T038507.20071005 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 05 October 2007 | ||||||||
Case number: | T 0385/07 | ||||||||
Application number: | 02770106.9 | ||||||||
IPC class: | A61K 38/15 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Use of aplidine for the treatment of pancreatic cancer | ||||||||
Applicant name: | PHARMA MAR, S.A. | ||||||||
Opponent name: | - | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Main request: clarity (yes) Added subject-matter (no) Novelty (yes) Inventive step (yes) Remittal (yes) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t070385eu1.html
Date retrieved: 17 May 2021
7 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.Case Law Book: I Patentability
XCLR I C 7.2.4.I Discovery of a previously unknown property of a compound underlying the known effect